Compare Stocks: MTD vs. TMO vs. DHR

Market Snapshot

Current market context for the selected companies.

MTD

$1,395.25

Market Cap —

Sector Healthcare

Industry Life Sciences Tools

Data through 2026-08-21

TMO

$629.27

Market Cap $232.67B

Sector Healthcare

Industry Life Sciences Tools

Data through 2026-08-21

DHR

$218.85

Market Cap $153.85B

Sector Healthcare

Industry Life Sciences Tools

Data through 2026-08-21

Performance

Absolute returns and relative performance versus SPY.

Metric	MTD	TMO	DHR
1 Month	+4.8%	+10.0%	+13.7%
1 Month vs SPY	+1.0%	+6.2%	+10.0%
3 Months	+28.0%	+40.0%	+26.3%
3 Months vs SPY	+24.9%	+36.9%	+23.2%
6 Months	+1.3%	+23.2%	+4.5%
6 Months vs SPY	-9.8%	+12.1%	-6.6%
1 Year	+6.0%	+27.2%	+3.5%
1 Year vs SPY	-14.0%	+7.2%	-16.5%
2 Years	—	+4.2%	-18.7%
2 Years vs SPY	—	-34.0%	-56.9%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric	MTD	TMO	DHR
Revenue Growth	—	10.5%	5.5%
Earnings Growth	—	9.4%	59.7%
Gross Margin	—	41.0%	58.8%
Operating Margin	—	18.8%	19.8%
Net Margin	—	15.0%	15.9%
Return on Equity	—	13.5%	7.6%
Return on Assets	—	5.1%	3.9%

Valuation

Common valuation multiples shown side by side.

Metric	MTD	TMO	DHR
P / E	—	33.8	37.7
Forward P / E	—	22.9	23.5
P / S	—	5.0	6.0
P / B	—	4.4	2.9
EV / Sales	—	5.7	6.9
EV / EBIT	—	30.6	34.7
P / FCF	—	37.2	35.1
FCF Yield	—	2.7%	2.8%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric	MTD	TMO	DHR
Free Cash Flow	—	$6.24B	$4.33B
Operating Cash Flow	—	$9.01B	$6.63B
Debt / Equity	—	80.6%	53.0%

Earnings Outlook

Upcoming earnings expectations when available.

Metric	MTD	TMO	DHR
Next Earnings	—	2026-10-21	2026-10-20
EPS Estimate	—	6.40	1.92
Revenue Estimate	—	11.95B	6.56B
EPS Growth	—	+10.6%	+1.4%
Revenue Growth	—	+7.5%	+8.4%
Analyst Coverage	—	22	20